Pancreaticobiliary maljunction (PBM) is a congenital anomaly where the bile and pancreatic ducts join outside the sphincter's area of action. This anatomical variation significantly influences pancreaticobiliary maljunction pathophysiology throughout a patient's entire lifespan. Clinicians usually classify PBM into two categories: dilated PBM involving choledochal cysts and nondilated PBM without biliary expansion. Consequently, the presentation of this condition varies greatly depending on the patient's age and the specific PBM type involved.

Symptoms often result from biliary obstruction caused by age-specific substances. For instance, neonates typically present with calcium bilirubinate debris, particularly in dilated PBM with narrow segments. Additionally, children often develop protein plugs due to pancreatobiliary reflux. However, these plugs rarely appear in the nondilated form of the disease. In contrast, adults frequently experience symptoms from gallstones. Specifically, bile duct stones are common in dilated PBM, whereas gallbladder stones may occur coincidently.

Clinical Impact of Pancreaticobiliary Maljunction Pathophysiology

The long-term effects of this condition are particularly concerning in the elderly population. Pancreatobiliary reflux can induce silent carcinogenesis, often leading to late-stage symptoms. Moreover, many adults with PBM remain asymptomatic for years. Furthermore, associated biliary strictures and pancreatobiliary regurgitation can produce obstructive substances or cancers. Therefore, early identification and management are crucial to mitigate these risks. Understanding the pancreaticobiliary maljunction pathophysiology allows for better-targeted diagnostic and therapeutic strategies across all age groups.

What are the primary symptoms of PBM in children?

Children often present with abdominal pain and vomiting. These symptoms are typically caused by protein plugs that obstruct the biliary or pancreatic ducts due to reflux.

How does PBM increase the risk of cancer?

The anomaly allows for continuous, unregulated pancreatobiliary reflux. This process induces chronic inflammation and silent carcinogenesis in the gallbladder and bile ducts, especially as patients age.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Kaneko K et al. Pathophysiology Underlying Manifestation of Pancreaticobiliary Maljunction Throughout Life. J Hepatobiliary Pancreat Sci. 2026 Apr 02. doi: 10.1002/jhbp.70110. PMID: 41924928.

Wang X et al. Pancreaticobiliary Maljunction: A Multidimensional Exploration of Pathophysiology, Diagnosis, Classification, Management and Research Prospects. Dig Dis Sci. 2025 Jun;70(6):1966-1975. doi: 10.1007/s10620-025-09057-0.

Zhang L et al. Clinical presentations and outcomes of pancreaticobiliary maljunction in different pediatric age groups. BMC Pediatr. 2023 Aug 26;23(1):425. doi: 10.1186/s12887-023-04248-y.